'Recessive Dystrophic Epidermolysis Bullosa (RDEB) is the worst disease you've probably never heard of,' says dermatology researcher Andrew South, Ph.D.. RDEB patients and their families know just how horrible it can be.
Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease retrieved 17 July 2024 from https://medicalxpress.com/news/2024-07-repurposing-fda-drugs-decrease-fibrosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jul 16, 2024 Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Genetics of Alzheimer's disease: First identification of a strong recessive componentA new study from deCODE genetics and collaborators is the first to uncover a strong recessive component in Alzheimer's disease.
Read more »
Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trialDrugs developed to combat HIV and AIDS are being trialed for the first time in patients with multiple brain tumors.
Read more »
Repurposing cancer drug to prevent organ damage in infectious diseasesTwelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue.
Read more »
Repurposing pemafibrate to treat liver disease associated with metabolic disordersThe University of Barcelona has led a study that suggests using the drug known as pemafibrate to treat liver disease associated with metabolic disorders, the most common liver pathology in the world, which affects one in four people.
Read more »
Safety of generic Viagra, other drugs called into doubt after false data found by FDAGeneric versions of erectile dysfunction drugs Viagra and Cialis, among other medications, were allowed on the U.S. market using potentially problematic data that call into question their safety and efficacy, a Bloomberg analysis found.
Read more »
FDA expands pediatric indication for RinvoqThe U.S. Food and Drug Administration has expanded indications for AbbVie's Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic arthritis (PsA).
Read more »